Thiopurine Therapy in Inflammatory Bowel Diseases: Making New Friends Should Not Mean Losing Old Ones

Gastroenterology. 2019 Jan;156(1):11-14. doi: 10.1053/j.gastro.2018.11.039. Epub 2018 Nov 22.

Authors

Nanne K H de Boer¹; Thiopurine Working Group²

Collaborators

Thiopurine Working Group:
Vineet Ahuja, Sven Almer, Azhar Ansari, Rupa Banerjee, Murray L Barclay, Jake Begun, Adriaan A van Bodegraven, Jean-Frederic Colombel, David P Epstein, Timothy H J Florin, Richard B Gearry, Javier P Gisbert, Rupert W Leong, Chris J J Mulder, Markus F Neurath, Graham L Radford-Smith, Margien L Seinen, Melek Simsek, Miles P Sparrow

Affiliations

¹ Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Gastroenterology and Hepatology, AG&M Research Institute, Amsterdam, the Netherlands. Electronic address: khn.deboer@vumc.nl.
² Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Gastroenterology and Hepatology, AG&M Research Institute, Amsterdam, the Netherlands.

PMID: 30472233
DOI: 10.1053/j.gastro.2018.11.039

No abstract available

Publication types

Editorial
Comment

MeSH terms

Azathioprine*
Friends*
Humans
Inflammatory Bowel Diseases

Substances

Azathioprine